Game Creek Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Game Creek Capital's ABBV Position: Q1 2022 in Review
Game Creek Capital sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 9,375 shares — an estimated $1.27M sold.
Game Creek Capital first reported a position in ABBV in Q4 2017 and held it in 14 quarters. The position peaked at $4.68M in Q2 2020. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.
- Game Creek Capital reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
- Game Creek Capital sold 9,375 AbbVie shares in Q1 2022, an estimated $1.27M.
- Game Creek Capital first reported a position in AbbVie in Q4 2017 and held it in 14 quarters.
- Game Creek Capital's AbbVie position peaked at $4.68M in Q2 2020.
- 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.
Based on Game Creek Capital's 13F filing for Q1 2022, filed 13 May 2022.